A

AnaCardio

11 employees

AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Medical
Biopharma

Date founded

2017

Funding rounds raised

Total raised

$14M

from 5 investors over 5 rounds

A

AnaCardio raised $14M on September 7, 2022

Investors: 3B ventures, Flerie Invest and Industrifonden

A

AnaCardio raised $3.6M on February 3, 2022

Investors: Karolinska Development

A

AnaCardio raised undisclosed on June 17, 2021

Investors: Karolinska Development

FAQ